Comparative Testing of Various Pancreatic Cancer Stem Cells Results in a Novel Class of Pancreatic-Cancer–Initiating Cells

No systemic therapy is effective against pancreatic cancer (PC). Pancreatic cancer stem cells (PCSC) are hypothesized to account for therapeutic resistance. Several PCSC subpopulations were reported, each characterized by different markers. To be able to target PCSC, we sought to better define this...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Jaiswal, Kshama R., Xin, Hong-Wu, Anderson, Andrew, Wiegand, Gordon, Kim, Bo, Miller, Tyler, Hari, Danielle, Ray, Satyajit, Koizumi, Tomotake, Rudloff, Udo, Thorgeirsson, Snorri S., Avital, Itzhak
التنسيق: Artigo
اللغة:Inglês
منشور في: 2012
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490042/
https://ncbi.nlm.nih.gov/pubmed/22963768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.scr.2012.08.001
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة